Abstracts Archive - Page 1149 of 2425 - ACR Meeting Abstracts

Abstract Number: 2167 • 2018 ACR/ARHP Annual Meeting
Incidence and Baseline Characteristics of Exacerbation in Patients with Interstitial Pneumonia with Autoimmune Features: A Single Center Large-Scale Cross-Sectional Cohort Study
Okinori Murata, Nobuhito Sasaki and Makoto Maemondo, Division of Pulmonary medicine, Allergy, and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan
Background/Purpose: Patients with idiopathic interstitial pneumonia (IIP) may have features of connective tissue diseases (CTDs). The term interstitial pneumonia with autoimmune features (IPAF) has been…
Abstract Number: 2168 • 2018 ACR/ARHP Annual Meeting
Seasonal Variation in Incidence of Polymyalgia Rheumatica: A Population-Based
Shafay Raheel¹, Cynthia S. Crowson² and Eric L. Matteson³, ¹St. Joseph's Hospital, Chicago, IL, ²Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, ³Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN
Background/Purpose: To determine whether there is a seasonal peak onset of polymyalgia rheumatica (PMR). We examined the seasonal variability of PMR in a geographically-defined population.Methods:…
Abstract Number: 2169 • 2018 ACR/ARHP Annual Meeting
Temporal Trends in Mortality in Patients Hospitalized for Cerebrovascular Events with Psoriatic Arthritis: Data from the Healthcare Cost and Utilization Project from 2010-2014
Shraddha Jatwani¹, Karan Chugh², Karan Jatwani³, Stuthi Perimbeti⁴, Vivek Modi⁵, Jasleen Kaur⁶ and Rakesh K Sharma⁷, ¹Department of Internal Medicine, Division of Rheumatology, Henry Ford Allegiance Health, Jackson, MI, ²Division of Pulmonary, Critical Care & Sleep, Wayne State University/Detroit Medical Center, Detroit, MI, ³Department of Internal Medicine, Mount Sinai West - St Luke’s Hospital, New York, NY, ⁴Department of Internal Medicine, Mount Sinai West - St Luke’s Hospital,, NEW YORK, NY, ⁵Department of Internal Medicine, Mount Sinai West - St Luke’s Hospital,, New York, NY, ⁶Department of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, MI, ⁷Department of Medicine, Postgraduate Institute of Medical Education & Research, Chandigarh, India
Background/Purpose: Cerebrovascular disease risk in increased in patients of Psoriatic arthritis (PsA), as reported in the literature. Epidemiological studies to assesses average annual trends are…
Abstract Number: 2170 • 2018 ACR/ARHP Annual Meeting
Relationship between Short- and Long-Term Periods of Self-Reported Physical Activity Patterns in Individuals with SLE
Gizem Irem Kinikli¹, Susanne Pettersson², Iva Gunnarsson³, Elisabet Svenungsson³ and Carina Boström⁴, ¹Physiotherapy and Rehabilitation, Hacettepe University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Ankara/TURKEY, Ankara, Turkey, ²Neurobiology, care sciences and society, Karolinska Institutet, Department of Neurobiology, care sciences and society, Karolinska University Hospital, Stockholm/SWEDEN, Stockholm, Sweden, ³Division of Rheumatology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden, ⁴Karolinska University Hospital, Karolinska Institutet, Department of Neurobiology, care sciences and society, Karolinska University Hospital, Stockholm/SWEDEN, Stockholm, Sweden
Background/Purpose: Physical inactivity is prevalent in Systemic Lupus Erythematosus (SLE). Assessment of physical activity (PA) is vital to manage cardiovascular risk factors in SLE. The…
Abstract Number: 2171 • 2018 ACR/ARHP Annual Meeting
A 5-Year National Trend in Acute Myocardial Infarctionamong Hospitalized Patients with Psoriatic Arthritis: Data from National Inpatient Sample
Shraddha Jatwani¹, Karan Chugh², Karan Jatwani³, Vivek Modi⁴ and Jasleen Kaur⁵, ¹Department of Internal Medicine, Division of Rheumatology, Henry Ford Allegiance Health, Jackson, MI, ²Division of Pulmonary, Critical Care & Sleep, Wayne State University/Detroit Medical Center, Detroit, MI, ³Department of Internal Medicine, Mount Sinai West - St Luke’s Hospital, New York, NY, ⁴Department of Internal Medicine, Mount Sinai West - St Luke’s Hospital,, New York, NY, ⁵Department of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, MI
Background/Purpose: Psoriatic arthritis (PsA) is associated with an increased risk of cardiovascular morbidity and mortality. The increase in cardiovascular risk evaluated in a meta-analysis on…
Abstract Number: 2172 • 2018 ACR/ARHP Annual Meeting
Overuse of Glucocorticoids in Rheumatoid Arthritis: A National Survey of Primary Care Physicians
Beth Wallace^1,2, Akbar Waljee^2,3,4, Arlene Weissman⁵, Tanner Caverly^2,6,7 and Sameer Saini^2,6,8, ¹Department of Internal Medicine, Division of Rheumatology, Michigan Medicine, Ann Arbor, MI, ²University of Michigan Institute for Healthcare Policy and Innovation, Ann Arbor, MI, ³Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI, ⁴Department of Internal Medicine, Division of Gastroenterology and Hepatology, Michigan Medicine, Ann Arbor, MI, ⁵Research Center at American College of Physicians, Philadelphia, PA, ⁶Center for Clinical Management Research, VA Ann Arbor Health Care System, Ann Arbor, MI, ⁷Michigan Medicine Department of Internal Medicine, Division of General Medicine, Ann Arbor, MI, ⁸Michigan Medicine Department of Internal Medicine, Division of Gastroenterology and Hepatology, Ann Arbor, MI
Background/Purpose: Most patients with RA receive oral glucocorticoids (GC) such as prednisone, despite concerns about safety. We sought to evaluate how primary care physicians (PCPs)…
Abstract Number: 2173 • 2018 ACR/ARHP Annual Meeting
Budget Impact of Etanercept Versus Adalimumab for Treatment of Rheumatoid Arthritis in Biologic-Naïve Patients in the United Kingdom
Kateryna Onishchenko¹, Miriam Tarallo², Cinzia Curiale² and Stamatia Theodora Alexopoulos¹, ¹Consulting at McCann Health, London, United Kingdom, ²Pfizer, Rome, Italy
Background/Purpose: Etanercept and adalimumab are TNFα inhibitors, both indicated in the UK for the treatment of patients with moderate-to-severe active RA who had inadequate response…
Abstract Number: 2174 • 2018 ACR/ARHP Annual Meeting
Self-Report of Fracture History Compared to Fracture Codes from an Electronic Health Record Dataset
Maria I. Danila¹, Amy S. Mudano¹, Elizabeth J. Rahn², Andrea Z. LaCroix^3,4, Jeffrey R. Curtis¹ and Kenneth Saag¹, ¹University of Alabama at Birmingham, Birmingham, AL, ²Department of Medicine, Division of Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ³University of California San Diego, La Jolla, CA, ⁴Group Health Cooperative, Seattle, WA
Background/Purpose: Self-reported fracture (fx) history data is frequently used in epidemiological studies of osteoporosis. Self-reported fx data may differ from fx history coded in electronic…
Abstract Number: 2175 • 2018 ACR/ARHP Annual Meeting
Change in Frequency of Arthroplasty Surgery in Rheumatoid Arthritis: A 13-Year Population Health Study
John G. Hanly¹, Lynn Lethbridge² and Chris Skedgel³, ¹Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada, ²Nova Scotia Health Authority, Halifax, NS, Canada, ³Dalhousie University, Halifax, NS, Canada
Background/Purpose: Improvement in the medical management of rheumatoid arthritis (RA) over the past two decades may have reduced the need for arthroplasty surgery but the…
Abstract Number: 2176 • 2018 ACR/ARHP Annual Meeting
The Association of Gout with Incident Giant Cell Arteritis in Older Adults
Jasvinder A. Singh and John Cleveland, Rheumatology, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Giant cell arteritis (GCA) is a vasculitis that affects large and medium sized arteries in people 50 years or older. Gout, the most common…
Abstract Number: 2177 • 2018 ACR/ARHP Annual Meeting
Workforce Requirements in Rheumatology: A Systematic Literature Reviewinforming the Development of a Workforce Prediction Risk of Bias Tool and the EULAR Points to Consider
Polina Putrik¹, Julia Unger², Frank Buttgereit³, Daniel Aletaha⁴, Gerolamo Bianchi⁵, Johannes W. J. Bijlsma⁶, Annelies Boonen⁷, Nada Cikes⁸, Joao Madruga Dias⁹, Louise Falzon¹⁰, Axel Finckh¹¹, Laure Gossec^12,13, Tore Kvien¹⁴, Eric L. Matteson¹⁵, Francisca Sivera¹⁶, Tanja Stamm¹⁷, Zoltan Szekanecz¹⁸, Dieter Wiek¹⁹, Angela Zink²⁰, Christian Dejaco²¹ and Sofia Ramiro^22,23, ¹Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, ²FH JOANNEUM, University of Applied Sciences, Institute of Occupational Therapy, Bad Gleichenberg, Austria, ³Department of Rheumatology and Clinical Immunology, Charité University Hospital Berlin, Berlin, Germany, ⁴Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Vienna, Austria, ⁵Rheumatology, ASL3-Azienda Sanitaria Genovese, Genua, Italy, ⁶Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, ⁷Caphri Research Institute, Maastricht, Netherlands, ⁸University of Zagreb School of Medicine, Zagreb, Croatia, ⁹Centro Hospitalar Médio Tejo, Torres Novas, Portugal, ¹⁰Center for Behavioral Cardiovascular Health, Columbia University Medical Center, New York, NY, ¹¹University Hospital of Geneva, Geneva, Switzerland, ¹²Rheumatology, Sorbonne Université, Paris, France, ¹³Rheumatology, Pitié Salpêtrière Hospital, Paris, France, ¹⁴Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ¹⁵Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, ¹⁶Rheumatology, Hospital General Universitario de Elda. Comunidad Valenciana. Spain, Elda, Spain, ¹⁷Section for Outcomes Research, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Vienna, Austria, ¹⁸Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary, Debrecen, Hungary, ¹⁹EULAR Standing Committee of PARE, Zurich, Switzerland, ²⁰Epidemiology Unit / Rheumatology and Clinical Immunology, German Rheumatism Research Centre (DRFZ) / Charité University Hospital, Berlin, Germany, ²¹Rheumatology and Immunology, Medical University Graz, Graz, Austria, ²²Department of Rheumatology, Leiden University Medical Centre, Leiden, Netherlands, ²³Department of Rheumatology, Zuyderland Medical Center, Heerlen, Netherlands
Background/Purpose: The projections from existing workforce studies in rheumatology vary by a factor of five, largely due to methodological heterogeneity. The purpose of this study…
Abstract Number: 2178 • 2018 ACR/ARHP Annual Meeting
Provider Perceptions of Telerheumatology within the Veterans Health Administration: A National Survey Study
Rachel A. Matsumoto¹, Bryant R. England², Ginnifer Mastarone^3,4, Linda Ganzini^1,5, J. Steuart Richards⁶, Elizabeth Chang⁷, Patrick R. Wood⁸ and Jennifer Barton^1,5, ¹VA Portland Health Care System, Portland, OR, ²Rheumatology, VA Nebraska-Western Iowa Health Care System & University of Nebraska Medical Center, Omaha, NE, ³Center to Improve Veteran Involvement in Care/VA Portland Health Care System, Portland, OR, ⁴Oregon Health & Science University - Portland State University School of Publich Health, Portland, OR, ⁵Oregon Health & Science University, Portland, OR, ⁶Pittsburgh VA Medical Center and University of Pittsburgh, Pittsburgh, PA, ⁷Rheumatology, Phoenix VAHCS, Phoenix, AZ, ⁸Rheumatology, Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO
Background/Purpose: Technological advancements and a need to improve access to care due to projected workforce shortages have led to a surge in telehealth use over…
Abstract Number: 2179 • 2018 ACR/ARHP Annual Meeting
Poor Rates of Screening for Retinal Toxicity in Patients on Antimalarial Medications: A Population-Based Study
Ksenia Gukova¹, John M. Esdaile², Hamid Tavakoli³ and J. Antonio Avina-Zubieta^1,2, ¹Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada, ²Arthritis Research Canada, Richmond, BC, Canada, ³Arthritis Research Canada, Vancouver, BC, Canada
Background/Purpose: Antimalarial drugs (AM) are commonly used to treat rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). AM can be associated with retinal toxicity that…
Abstract Number: 2180 • 2018 ACR/ARHP Annual Meeting
Differences in Longitudinal Disease Activity Measures between Research Cohort and Non-Cohort Participants with Rheumatoid Arthritis Using Electronic Health Record Data
Milena Gianfrancesco¹, Laura Trupin¹, Charles McCulloch², Stephen Shiboski³, Jonathan Graf⁴, Gabriela Schmajuk⁵ and Jinoos Yazdany⁶, ¹Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ²Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, ³Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, ⁴Department of Medicine, Division of Rheumatology Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, ⁵San Francisco VA Medical Center, San Francisco, CA, ⁶University of California, San Francisco, San Francisco, CA
Background/Purpose: Research using electronic health records (EHR) may offer advantages over traditional observational studies, including lower costs and greater generalizability to a broader patient population;…
Abstract Number: 2181 • 2018 ACR/ARHP Annual Meeting
Development and Feasibility of a Web-Based Data Capture System to Collect Uniform Comprehensive Post-Total Knee Replacement Physical Therapy Intervention Data for Both Clinical and Research Purposes
Carol A. Oatis¹, Marie Westby², Wilfred Peter³, Celeste Lemay⁴, Nathan Taber⁵ and Patricia D. Franklin⁶, ¹Physical Therapy, Arcadia Univ, Glenside, PA, ²Centre for Hip Health and Mobility, Vancouver, BC, Canada, ³Department of Orthopeadics, Leiden University Medical Center, Leiden, Netherlands, ⁴Orthopedics, University of Massachusetts Medical School, Worcester, MA, ⁵Orthopedics and Rehabilitation, University of Massachusetts Medical School, Worcester, MA, ⁶Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worchester, MA
Background/Purpose: Total knee replacement surgery (TKR) for osteoarthritis is a highly prevalent treatment with widely variable functional outcomes. Most patients receive physical therapy (PT) following…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].